Zenas BioPharma, Inc. Investment Income, Interest
Zenas BioPharma, Inc. (ZBIO) reported Investment Income, Interest of $6.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- Zenas BioPharma, Inc. investment income, interest for the quarter ending 2026-06-30 was $6.60M, a 140.72% increase year-over-year.
- Zenas BioPharma, Inc. investment income, interest for the quarter ending 2026-03-31 was $3.02M, a 11.08% decline year-over-year.
- Zenas BioPharma, Inc. investment income, interest for the quarter ending 2025-06-30 was $2.74M.
- Zenas BioPharma, Inc. investment income, interest for the quarter ending 2025-03-31 was $3.39M.
- Zenas BioPharma, Inc. investment income, interest for fiscal 2025 was $12.15M, a 52.40% increase from fiscal 2024.
- Zenas BioPharma, Inc. investment income, interest for fiscal 2024 was $7.97M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 12 month |
|---|---|---|---|
| 2026-06-30 | $6.60M 10-Q · filed 2026-08-13 | $9.62M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.02M 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | $12.15M 10-K · filed 2026-03-16 | ||
| 2025-06-30 | $2.74M 10-Q · filed 2026-08-13 | $6.14M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $3.39M 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | $7.97M 10-K · filed 2026-03-16 |